Navigation Links
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Date:10/4/2007

SOUTH SAN FRANCISCO, Calif., Oct. 4 /PRNewswire/ -- Hyperion Therapeutics, Inc., a privately-held biopharmaceutical company focused on the development and commercialization of gastrointestinal and hepatology therapies that address underserved patient populations or unmet medical needs today announced key senior management appointments and closing of up to $15 million in debt financing from Comerica Bank and Life Sciences Capital. Joining Co-Founder Chris Rivera (President and CEO) are Marvin Garovoy, M.D. (Senior Vice President (SVP), Clinical Development), Sharron Gargosky, PhD (Chief Scientific Officer and SVP of Corporate Development), Klara Dickinson (SVP, Regulatory Affairs and Compliance), Kevin Weber (SVP, Global Strategy and Operations), Wayne Davis, PhD (Vice President, Clinical Operations), Hoi Leung, PhD (Vice President, Biostatistics), George Jue (Vice President, Finance and Controller), and James Kaser (Vice President, Global Sales).

(Logo: http://www.newscom.com/cgi-bin/prnh/20070905/AQW076LOGO)

"The build out of our senior management team and infusion of additional financial capital provides a solid foundation for Hyperion to fulfill its commitments and capitalize on the opportunity presented by our recently announced strategic collaboration with Ucyclyd Pharma, Inc., a subsidiary of Medicis Pharmaceutical Corporation," said Chris Rivera, President and CEO. "This team brings a unique and proven track record of developing, gaining regulatory approval and building orphan and specialty markets. I look forward to working with them to build a leading biopharmaceutical company and to make a difference in patients' lives."

About the Management Team

Chris E. Rivera, President and CEO, co-founded Hyperion Therapeutics in 2006, and led the execution of the Ucyclyd Pharma collaboration agreement. Prior to joining Hyperion, Mr. Rivera was Senior Vice
'/>"/>

SOURCE Hyperion Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... , Aug. 5, 2015  MabVax Therapeutics Holdings, Inc. ... immuno-oncology drug development company, announces the posting of the ... Officer David Hansen to the Company,s website ... You have invested in MabVax Therapeutics because ... the treatment of difficult cancers.  You also share our ...
(Date:8/5/2015)... Switzerland (PRWEB) , ... August 05, 2015 , ... ... solutions for production, culture, and assessment of more organotypic 3D cell culture models, ... GravityTRAP™ Ultra-Low Attachment (ULA) Plates are now available for purchase exclusively ...
(Date:8/4/2015)... Aug. 4, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... financial results for the quarter ending June 30, 2015. Highlights ... in June 2015 , The final cost of ... or $4.0 million above the high end of the ... million +/- 10%) , The company announced commercial ...
(Date:8/4/2015)... ... August 04, 2015 , ... RPS Diagnostics (RPS®) ... today announced that Robert A. Gregg, PhD, has joined RPS as Senior Vice ... of relevant experience and remarkable achievements in the medical device and diagnostics industries. ...
Breaking Biology Technology:MabVax Therapeutics Issues Letter to Stockholders 2MabVax Therapeutics Issues Letter to Stockholders 3MabVax Therapeutics Issues Letter to Stockholders 4MabVax Therapeutics Issues Letter to Stockholders 5MabVax Therapeutics Issues Letter to Stockholders 6MabVax Therapeutics Issues Letter to Stockholders 7MabVax Therapeutics Issues Letter to Stockholders 8MabVax Therapeutics Issues Letter to Stockholders 9MabVax Therapeutics Issues Letter to Stockholders 10MabVax Therapeutics Issues Letter to Stockholders 11MabVax Therapeutics Issues Letter to Stockholders 12MabVax Therapeutics Issues Letter to Stockholders 13InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms 2InSphero Expands Global Availability of its Patented 3D Cell Culture Platforms 3BioAmber Reports Second Quarter 2015 Financial Results 2BioAmber Reports Second Quarter 2015 Financial Results 3BioAmber Reports Second Quarter 2015 Financial Results 4BioAmber Reports Second Quarter 2015 Financial Results 5BioAmber Reports Second Quarter 2015 Financial Results 6BioAmber Reports Second Quarter 2015 Financial Results 7BioAmber Reports Second Quarter 2015 Financial Results 8BioAmber Reports Second Quarter 2015 Financial Results 9BioAmber Reports Second Quarter 2015 Financial Results 10BioAmber Reports Second Quarter 2015 Financial Results 11BioAmber Reports Second Quarter 2015 Financial Results 12RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3
... ... awarded a $2.18 million grant to Aciont Inc. to help fund its development of a ... ... The National Eye Institute (NEI), a division of the National Institutes of Health (NIH), awarded ...
... ... Brooks Instrument, a world-leading provider of advanced flow measurement, ... company as Global Level Product Manager effective November 30, 2009. He ... level measurement products around the world. He is joining Brooks Instrument ...
... , , SAN DIEGO, Dec. ... stabilization, today announces the release of SampleWare 3.1 software system ... latest release now includes an audit trail functionality that tracks ... of any stored sample. , The addition of the ...
Cached Biology Technology:NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3
(Date:7/30/2015)... , July 30, 2015 Cellecta, Inc., ... gene function analysis and biomarker discovery, announced the ... Knockout Library targeting all human protein coding genes. ... "knock out" a gene,s function. Cellecta,s new Human ... throughput screening tool so that researchers can investigate ...
(Date:7/23/2015)... 23, 2015 Research and Markets ( ... "Global Outlook of the Biometrics Industry 2015 ... The global biometrics market is likely to ... applications owing to the uptake of multiple technologies ... that enhances the growth of biometrics in existing ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
Breaking Biology News(10 mins):CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... an astonishing abundance, diversity and distribution of deep sea species ... a living in a frigid black world down to 5,000 ... via deep-towed cameras, sonar and other vanguard technologies, animals known ... a diverse collection of species ranging from crabs to shrimp ...
... 2009 Agios Pharmaceuticals today announced that its scientists ... IDH1 gene has a novel enzyme activity consistent with ... that the mutated form of IDH1 produces a metabolite, ... malignant progression of gliomas, the most common type of ...
... NJIT researchers are at work on many scientific and ... support that totals nearly $4.3 million for the diverse ... and Reinvestment Act of 2009. Four researchers ... Philip R. Goode, distinguished professor of physics, will enhance ...
Cached Biology News:Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2
Mouse monoclonal [GB3] to Kalinin ( Abpromise for all tested applications). entrezGeneID: 3918 SwissProtID: Q13753...
Phospho-4E-BP1 (Thr37/46) (236B4) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
Phospho-TAK1 (Thr184/187) (90C7) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
... ( Abpromise for all tested ... Synthetic peptide derived from within residues ... MSY2/YBOX2. (Note: the amino acid ... (Peptide available as ab27460 .) ...
Biology Products: